374
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Neuroendocrine aspects of migraine in women

&
Pages 37-41 | Published online: 07 Mar 2012

References

  • The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24(suppl 1):9–160.
  • Silberstein SD. The role of sex hormones in headache. Neurology 1992;42:37–42.
  • Silberstein SD. Sex hormones and headache. Rev Neurol (Paris) 2000;156 Suppl 4:4S30–4S41.
  • Nappi G, Costa A, Tassorelli C, Santorelli FM. Migraine as a complex disease: heterogeneity, comorbidity and genotype-phenotype interactions. Funct Neurol 2000;15:87–93.
  • Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005;45 Suppl 1:S3–S13.
  • Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia 1992;12:238–43; discussion 186.
  • Rasmussen BK. Epidemiology of headache. Cephalalgia 1995;15:45–68.
  • Welch KM, Darnley D, Simkins RT. The role of estrogen in migraine: a review and hypothesis. Cephalalgia 1984;4:227–236.
  • MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol 2004;3:354–361.
  • Welch KM, Brandes JL, Berman NE. Mismatch in how oestrogen modulates molecular and neuronal function may explain menstrual migraine. Neurol Sci 2006;27 Suppl 2:S190–S192.
  • Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA 2006;295:1824–1830.
  • Eikermann-Haerter K, Kudo C, Moskowitz MA. Cortical spreading depression and estrogen. Headache 2007;47 Suppl 2:S79–S85.
  • Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64–69.
  • Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol 1991;134:1111–1120.
  • Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis – part 1. Headache 2006;46:3–23.
  • Martin VT, Behbehani M. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis − part 2. Headache 2006;46:365–386.
  • Fioroni L, Martignoni E, Facchinetti F. Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia 1995;15:297–300.
  • Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000;20:701–707.
  • Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000;55:1517–1523.
  • Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache 2003;43:27–35.
  • Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993;33:385–389.
  • Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355–365.
  • Nappi RE, Berga SL. Migraine and reproductive life. Handb Clin Neurol 2010;97:303–322.
  • MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006;67:2154–2158.
  • Martin VT, Wernke S, Mandell K, Ramadan N, Kao L, Bean J, Liu J, et al. Defining the relationship between ovarian hormones and migraine headache. Headache 2005;45:1190–1201.
  • Facchinetti F, Neri I, Martignoni E, Fioroni L, Nappi G, Genazzani AR. The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993;13:422–425.
  • Nappi G, Jensen R, Nappi RE, Sances G, Torelli P, Olesen J. Diaries and calendars for migraine. A review. Cephalalgia 2006;26:905–916.
  • Couturier EG, Bomhof MA, Neven AK, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003;23:302–308.
  • Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C, Brundu B, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 2004;24:707–716.
  • MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004;63:351–353.
  • Nappi RE, Sances G, Brundu B, Ghiotto N, Detaddei S, Biancardi C, Polatti F, Nappi G. Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. Neuroendocrinology 2003;78:52–60.
  • Nappi RE, Sances G, Brundu B, De Taddei S, Sommacal A, Ghiotto N, Polatti F, Nappi G. Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval. Hum Reprod 2005;20:3423–3428.
  • Martin V, Wernke S, Mandell K, Zoma W, Bean J, Pinney S, Liu J, et al. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache. Headache 2003;43:309–321.
  • de Lignières B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986;293:1540.
  • Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988;2:113–120.
  • Pradalier A, Vincent D, Beaulieu P, Baudesson G, Launay J. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In: Rose C, editor. New advances in headache research. 4th ed. London: Smith-Gordon; 1994. pp 129–132.
  • MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 2006;67:2159–2163.
  • Almén-Christensson A, Hammar M, Lindh-Åstrand L, Landtblom AM, Brynhildsen J. Prevention of menstrual migraine with perimenstrual transdermal 17-ß-estradiol: a randomized, placebo-controlled, double-blind crossover study. Fertil Steril 2011;96:498–500.e1.
  • Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache 2006;46:794–803.
  • Nappi RE, Albani F, Sances G, Terreno E, Brambilla E, Polatti F. Headaches during pregnancy. Curr Pain Headache Rep 2011;15:289–294.
  • Marcus DA. Headache in pregnancy. Curr Pain Headache Rep 2003;7:288–296.
  • Aegidius K, Zwart JA, Hagen K, Stovner L. The effect of pregnancy and parity on headache prevalence: the Head-HUNT study. Headache 2009;49:851–859.
  • Somerville BW. A study of migraine in pregnancy. Neurology 1972;22:824–828.
  • Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, Nappi G. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003;23:197–205.
  • Lee LK. Physiological adaptations of pregnancy affecting the nervous system. Semin Neurol 2007;27:405–410.
  • Genazzani AR, Petraglia F, Facchini V, Facchinetti F. Circulating beta-endorphin levels at various stages of life: possible connections with migraine pathogenesis. Cephalalgia 1983;3 Suppl 1:35–41.
  • Petraglia F, Florio P, Nappi C, Genazzani AR. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev 1996;17:156–186.
  • Facchinetti F, Allais G, Nappi RE, D’Amico R, Marozio L, Bertozzi L, Ornati A, Benedetto C. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia 2009;29:286–292.
  • Nappi RE, Sances G, Detaddei S, Ornati A, Chiovato L, Polatti F. Hormonal management of migraine at menopause. Menopause Int 2009;15:82–86.
  • Fettes I. Migraine in the menopause. Neurology 1999;53:S29–S33.
  • MacGregor EA, Barnes D. Migraine in a specialist menopause clinic. Climacteric 1999;2:218–223.
  • Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache 2003;43:470–478.
  • Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993;17:31–37.
  • Oldenhave A, Jaszmann LJ, Everaerd WT, Haspels AA. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 1993;168:765–771.
  • Aegidius KL, Zwart JA, Hagen K, Schei B, Stovner LJ. Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study. Eur J Neurol 2007;14:73–78.
  • Nappi RE, Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F. Course of primary headaches during hormone replacement therapy. Maturitas 2001;38:157–163.
  • Loder E, Rizzoli P, Golub J. Hormonal management of migraine associated with menses and the menopause: a clinical review. Headache 2007;47:329–340.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.